Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infections

Autor: Woei-A-Jin, F.J. Sherida H., van der Starre, Willize E., Tesselaar, Margot E.T., Garcia Rodriguez, Patricia, van Nieuwkoop, Cees, Bertina, Rogier M., van Dissel, Jaap T., Osanto, Susanne

Publikováno v: In Thrombosis Research May 2014 133(5):799-803

Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women.

Autor: van Nieuwkoop, Cees^1,2 c.vannieuwkoop@hagaziekenhuis.nl, van der Starre, Willize E.², Stalenhoef, Janneke E.², van Aartrijk, Anna M.², van der Reijden, Tanny J. K.², Vollaard, Albert M.², Delfos, Nathalie M.³, van 't Wout, Jan W.^2,4, Blom, Jeanet W.⁵, Spelt, Ida C.⁶, Leyten, Eliane M. S.⁷, Koster, Ted⁸, Ablij, Hans C.⁹, van der Beek, Martha T.¹⁰, Knol, Mirjam J.¹¹, van Dissel, Jaap T.^2,11

Publikováno v: BMC Medicine. 4/3/2017, Vol. 15, p1-9. 9p. 1 Diagram, 3 Charts, 1 Graph.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Treatment duration of febrile urinary tract infections.

Autor: van der Starre WE; Department of Infectious Diseases, Leiden University Medical Center, Postbox 9600, 2300 RC, Leiden, the Netherlands, w.e.van_der_starre@lumc.nl., van Dissel JT, van Nieuwkoop C

Publikováno v: Current infectious disease reports [Curr Infect Dis Rep] 2011 Dec; Vol. 13 (6), pp. 571-8.